Prostate-Specific Antigen

"Prostate-Specific Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.

Descriptor ID	D017430
MeSH Number(s)	D08.811.277.656.300.760.442.750 D08.811.277.656.959.350.442.750 D12.776.866.249.500 D23.050.285.625 D23.101.140.625
Concept/Terms	Prostate-Specific Antigen Prostate-Specific Antigen gamma-Seminoprotein gamma Seminoprotein Prostate Specific Antigen hK3 Kallikrein Kallikrein, hK3 Semenogelase Kallikrein hK3 Seminin

Below are MeSH descriptors whose meaning is more general than "Prostate-Specific Antigen".

Chemicals and Drugs [D]
Enzymes and Coenzymes [D08]
Enzymes [D08.811]
Hydrolases [D08.811.277]
Peptide Hydrolases [D08.811.277.656]
Endopeptidases [D08.811.277.656.300]
Serine Endopeptidases [D08.811.277.656.300.760]
Kallikreins [D08.811.277.656.300.760.442]
Prostate-Specific Antigen [D08.811.277.656.300.760.442.750]
Serine Proteases [D08.811.277.656.959]
Serine Endopeptidases [D08.811.277.656.959.350]
Kallikreins [D08.811.277.656.959.350.442]
Prostate-Specific Antigen [D08.811.277.656.959.350.442.750]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Seminal Plasma Proteins [D12.776.866]
Prostatic Secretory Proteins [D12.776.866.249]
Prostate-Specific Antigen [D12.776.866.249.500]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Neoplasm [D23.050.285]
Prostate-Specific Antigen [D23.050.285.625]
Biomarkers [D23.101]
Biomarkers, Tumor [D23.101.140]
Prostate-Specific Antigen [D23.101.140.625]

Below are MeSH descriptors whose meaning is related to "Prostate-Specific Antigen".

Below are MeSH descriptors whose meaning is more specific than "Prostate-Specific Antigen".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Prostate-Specific Antigen" by people in this website by year, and whether "Prostate-Specific Antigen" was a major or minor topic of these publications.

Bar chart showing 105 publications over 24 distinct years, with a maximum of 11 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	1	0	1
2002	1	2	3
2003	1	1	2
2004	1	2	3
2005	0	1	1
2006	2	4	6
2007	1	2	3
2008	1	1	2
2009	1	3	4
2010	1	4	5
2011	2	2	4
2012	4	2	6
2013	2	2	4
2014	0	3	3
2015	6	4	10
2016	1	5	6
2017	3	3	6
2018	2	1	3
2019	1	1	2
2020	2	2	4
2021	3	3	6
2022	1	6	7
2023	3	8	11
2024	2	1	3

Below are the most recent publications written about "Prostate-Specific Antigen" by people in Profiles.

Garraway IP, Carlsson SV, Nyame YA, Vassy JL, Chilov M, Fleming M, Frencher SK, George DJ, Kibel AS, King SA, Kittles R, Mahal BA, Pettaway CA, Rebbeck T, Rose B, Vince R, Winn RA, Yamoah K, Oh WK. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States. NEJM Evid. 2024 May; 3(5):EVIDoa2300289.

View in: PubMed
Chiarelli G, Davis M, Stephens A, Cirulli GO, Finati M, Corsi NJ, Sood A, Tinsley S, Carrieri G, Briganti A, Montorsi F, Lughezzani G, Buffi N, Rogers C, Abdollah F. Comparison of patient background between a real-world North American cohort and the G?teborg-2 trial. Int J Urol. 2024 May; 31(5):562-567.

View in: PubMed
Noriega Landa E, Quaye GE, Su X, Badmos S, Holbrook KL, Polascik TJ, Adams ES, Deivasigamani S, Gao Q, Annabi MH, Habib A, Lee WY. Urinary fatty acid biomarkers for prostate cancer detection. PLoS One. 2024; 19(2):e0297615.

View in: PubMed
Dalela D, Corsi NJ, Bronkema C, Sood A, Arora S, Majdalany SE, Butaney M, Jamil M, Li P, Palma-Zamora I, Rakic N, Kovacevic N, Jeong W, Menon M, Rogers CG, Schonberg MA, Abdollah F. Prostate Specific Antigen Screening on a Nationwide Level: Featuring the Contribution of Race and Life Expectancy in Decision Making. Clin Genitourin Cancer. 2024 04; 22(2):269-280.e2.

View in: PubMed
Mistry NA, Sun Z, Sweis J, McCall C, Marshall N, Ofori B, Hollowell CMP, Kittles RA, Schaeffer EM, Abern M, Gann P, Murphy AB. Development and Validation of a Prostate Biopsy Risk Calculator in Black Men. J Urol. 2024 Feb; 211(2):223-233.

View in: PubMed
Zaorsky NG, Proudfoot JA, Jia AY, Zuhour R, Vince R, Liu Y, Zhao X, Hu J, Schussler NC, Stevens JL, Bentler S, Cress RD, Doherty JA, Durbin EB, Gershman S, Cheng I, Gonsalves L, Hernandez BY, Liu L, Morawski BM, Schymura M, Schwartz SM, Ward KC, Wiggins C, Wu XC, Shoag JE, Ponsky L, Dal Pra A, Schaeffer EM, Ross AE, Sun Y, Davicioni E, Petkov V, Spratt DE. Use of the Decipher genomic classifier among men with prostate cancer in the United States. JNCI Cancer Spectr. 2023 08 31; 7(5).

View in: PubMed
Sood A, Kishan AU, Evans CP, Feng FY, Morgan TM, Murphy DG, Padhani AR, Pinto P, Van der Poel HG, Tilki D, Briganti A, Abdollah F. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature. Eur Urol Oncol. 2024 Feb; 7(1):27-43.

View in: PubMed
Dalela D, Malchow T, Butaney M, Majdalany S, Corsi NJ, Rakic I, Sood A, Rogers C, Abdollah F. Temporal and Racial Trends in Prostate-specific Antigen Screening for U.S. Men With a Family History of Prostate Cancer. Urol Pract. 2023 09; 10(5):484-492.

View in: PubMed
Modonutti D, Majdalany SE, Butaney M, Davis MJ, Corsi N, Sood A, Trinh QD, Cole AP, Rogers CG, Novara G, Abdollah F. Conditional survival does not improve over time in metastatic castration-resistant prostate cancer patients undergoing docetaxel. Prostate. 2023 09; 83(13):1238-1246.

View in: PubMed
Andrews JR, Sood A, Chapin BF. Point-Counterpoint: Staging Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Detecting Clinically Node Positive Prostate Cancer. J Urol. 2023 08; 210(2):242-243.

View in: PubMed

People

Explore

Similar Concepts

Top Journals